Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 24304210)

1.

Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1.

Bdolah Y, Elchalal U, Natanson-Yaron S, Yechiam H, Bdolah-Abram T, Greenfield C, Goldman-Wohl D, Milwidsky A, Rana S, Karumanchi SA, Yagel S, Hochner-Celnikier D.

Hypertens Pregnancy. 2014 May;33(2):250-9. doi: 10.3109/10641955.2013.858745. Epub 2013 Dec 4.

PMID:
24304210
2.

Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?

Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, Lim KH, Bdolah-Abram T, Epstein FH, Karumanchi SA.

Am J Obstet Gynecol. 2008 Apr;198(4):428.e1-6. doi: 10.1016/j.ajog.2007.10.783. Epub 2008 Jan 14.

PMID:
18191808
3.

Circulating angiogenic proteins in trisomy 13.

Bdolah Y, Palomaki GE, Yaron Y, Bdolah-Abram T, Goldman M, Levine RJ, Sachs BP, Haddow JE, Karumanchi SA.

Am J Obstet Gynecol. 2006 Jan;194(1):239-45.

PMID:
16389038
4.

Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.

Govender N, Naicker T, Rajakumar A, Moodley J.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):100-5. doi: 10.1016/j.ejogrb.2013.05.021. Epub 2013 Jun 24.

PMID:
23806447
5.

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.

Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network.

PLoS One. 2010 Oct 11;5(10):e13263. doi: 10.1371/journal.pone.0013263.

6.

Maternal angiogenic profile in pregnancies that remain normotensive.

Faupel-Badger JM, Staff AC, Thadhani R, Powe CE, Potischman N, Hoover RN, Troisi R.

Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):189-93. doi: 10.1016/j.ejogrb.2011.05.001.

7.

Gestational angiogenic biomarker patterns in high risk preeclampsia groups.

Maynard SE, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Moore Simas TA.

Am J Obstet Gynecol. 2013 Jul;209(1):53.e1-9. doi: 10.1016/j.ajog.2013.03.017. Epub 2013 Mar 18.

PMID:
23517919
8.

Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.

Rizos D, Eleftheriades M, Karampas G, Rizou M, Haliassos A, Hassiakos D, Vitoratos N.

Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):225-30. doi: 10.1016/j.ejogrb.2013.08.040. Epub 2013 Sep 4.

PMID:
24035323
9.

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.

Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.

J Hypertens. 2012 Nov;30(11):2173-81. doi: 10.1097/HJH.0b013e328357c0c9.

PMID:
22902831
10.

Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.

Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR.

Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):33-9.

PMID:
15935542
11.

Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor.

Schmidt M, Dogan C, Birdir C, Callies R, Kuhn U, Gellhaus A, Janetzko A, Kimmig R, Kasimir-Bauer S.

Clin Chem Lab Med. 2007;45(11):1504-10.

PMID:
17970705
12.

The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.

Cohen AL, Wenger JB, James-Todd T, Lamparello BM, Halprin E, Serdy S, Fan S, Horowitz GL, Lim KH, Rana S, Takoudes TC, Wyckoff JA, Thadhani R, Karumanchi SA, Brown FM.

Hypertens Pregnancy. 2014 Feb;33(1):81-92. doi: 10.3109/10641955.2013.837175. Epub 2013 Dec 19.

13.

Maternal circulating angiogenic factors in twin and singleton pregnancies.

Faupel-Badger JM, McElrath TF, Lauria M, Houghton LC, Lim K, Parry S, Cantonwine D, Lai G, Karumanchi SA, Hoover RN, Troisi R.

Am J Obstet Gynecol. 2014 Nov 27. pii: S0002-9378(14)02359-X. doi: 10.1016/j.ajog.2014.11.035. [Epub ahead of print]

PMID:
25434840
14.

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA.

J Clin Invest. 2003 Mar;111(5):649-58.

15.

Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.

Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA.

J Clin Endocrinol Metab. 2005 Aug;90(8):4895-903. Epub 2005 May 10.

PMID:
15886253
16.

First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA.

J Clin Endocrinol Metab. 2004 Feb;89(2):770-5.

PMID:
14764795
17.

Effect of smoking on circulating angiogenic factors in high risk pregnancies.

Jeyabalan A, Powers RW, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

PLoS One. 2010 Oct 12;5(10):e13270. doi: 10.1371/journal.pone.0013270.

18.

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.

Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA.

Circulation. 2012 Feb 21;125(7):911-9. doi: 10.1161/CIRCULATIONAHA.111.054361. Epub 2012 Jan 18.

19.

Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies.

Staff AC, Harsem NK, Braekke K, Hyer M, Hoover RN, Troisi R.

Eur J Obstet Gynecol Reprod Biol. 2009 Mar;143(1):29-33. doi: 10.1016/j.ejogrb.2008.11.003. Epub 2009 Jan 8.

PMID:
19135290
20.

Angiogenic factors for the prediction of preeclampsia in high-risk women.

Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE.

Am J Obstet Gynecol. 2007 Sep;197(3):244.e1-8.

PMID:
17826405
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk